Health Condition 1: N209- Urinary calculus, unspecified
Conditions
Interventions
Intervention1: Epigaea Repens: Oral administration of Epigaea Repens in either 30 or 200 potency in form of globules size 40.
Dosage and Repeatition - bd or tds for seven days.
Sponsors
Dr MPK Homoeopathic Medical College Hospital and Research Center
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients giving consent for the study 2. Patients willing to have X-ray or USG (KUB) before and after treatment 3. Cases (symptomatic and asymptomatic) with radiological evidence (Ultrasound Whole Abdomen) of renal stone. No history of expulsion of calculi after the radiological investigations within one month period 4. Patients having any urinary symptoms due to renal stone 5. Only those cases will be selected which will be having symptom similarity with the medicine Epigaea Repens
Exclusion criteria
Exclusion criteria: 1. Females who want to conceive, are pregnant or lactating 2. Patients diagnosed with Chronic Kidney Disease, Nephrotic Syndrome 3. Cases of Hydronephrosis above grade II 4. Known cases of any other severe systemic disorders 5. Patient pursuing other treatment and are not willing to leave it 6. Gross developmental defects or structural abnormality of kidney
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| According to the scores obtained (pre and post treatment) from the Urolithiasis Symptom Scoring (USS) methodTimepoint: Pre scores will be taken at baseline of treatment and post scores will be assessed at the end of 12 weeks using Urolithiasis Symptom Scoring (USS) method | — |
Secondary
| Measure | Time frame |
|---|---|
| To verify the symptoms of Epigaea Repens in cases of UrolithiasisTimepoint: 12 months | — |
Countries
India
Contacts
Public ContactDr Komal Yadav
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Outcome results
None listed